The side effects of systemic chemotherapy used to treat cancer are often severe. For
decades, oncologists have focused on treating the tumor, which may result in damage to the …

In patients with inflammatory bowel disease (IBD), chronic inflammation is a major risk factor
for the development of gastrointestinal malignancies. The pathogenesis of colitis-associated …

Cancers Complicating Inflammatory Bowel Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

The global prevalence of cancer is increasing, largely as more patients are living into old
age. Therefore, gastroenterologists caring for patients with inflammatory bowel disease [IBD] …

Synthetic dyes and colourants have been the mainstay of the pigment industry for decades.
Researchers are eager to find a more environment friendly and non-toxic substitute because …

Mammalian target of rapamycin (mTOR) is a protein kinase that controls cell growth,
proliferation, and survival. mTOR signaling is often upregulated in cancer and there is great …

Parkinson's disease (PD) is the second most common neurodegenerative disease,
manifesting as a characteristic movement disorder with a number of additional non-motor …

Indoleamine 2, 3‐dioxygenase (IDO) degrades the essential amino acid tryptophan in
mammals, catalyzing the initial and rate‐limiting step in the de novo biosynthesis …

Regulatory T cells (Tregs) play an important role in maintaining immune tolerance and
homeostasis by modulating how the immune system is activated. Several studies have …

Neurodegenerative diseases (NDs) such as, Alzheimer's disease (AD), Parkinson's disease
(PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD), are defined by …